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Left Internal Mammary to LAD Artery Still Rules the Roost*Friedrich W. Mohr, MD, PHD, Piroze M. Davierwala, MDSEE PAGE 2717S igniﬁcant proximal left anterior descendingartery (LAD) disease may jeopardize up to50% of the left ventricular myocardium (1)
and predicts worse outcomes (2), with a signiﬁcantly
worse 5-year patient survival rate (90% vs. 98%)
than downstream LAD lesions (3). In the 1990s,
randomized controlled trials (RCTs) showed that all
treatment modalities, namely, medical therapy,
percutaneous transluminal coronary angioplasty
(PTCA), and surgery provided symptomatic relief,
but a signiﬁcantly smaller proportion of patients who
received only medical therapy were totally asymp-
tomatic. Left internal mammary artery (LIMA) bypass
was associated with a greater event-free probability
than either PTCA or medical treatment (4). Novel sur-
gical techniques, such as off-pump coronary artery
bypass graft (CABG) surgery and minimally invasive
direct coronary artery bypass (MIDCAB) surgery,
involving a LIMA to LAD bypass, gained widespread
acceptance, keeping pace with the introduction of
bare-metal stents (BMS) and drug-eluting stents
(DES), which revolutionized percutaneous coronary
intervention (PCI) by reducing restenosis rates (5).
This necessitated the performance of RCTs to compare
PCI with BMSs and/or DES and MIDCAB (2 by our
group [6–9]), which consistently associated PCI with
signiﬁcantly higher target vessel revascularization
(TVR) rates and correspondingly more major ad-
verse cardiac and cerebrovascular events (MACCE)*Editorials published in the Journal of the American College of Cardiology
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Forrester, MD, served as Guest Editor for this paper.(8,9). However, there were similar mortality and peri-
procedural myocardial infarction (MI) rates. However,
these studies included very few patients and had an
insufﬁcient number of events for adequate statistical
power. Two meta-analyses revealed similar ﬁndings,
with 1 identifying a higher occurrence of recurrent
angina after PCI (10,11). Furthermore, only 1 RCT uti-
lized DES (7). Because RCTs often include a select
group of patients, they introduce a degree of bias by
excluding those encountered in real-world scenarios.
This information can be derived from analyses of
data obtained from large registries that incorporate
details of patients treated in daily practice. Therefore,
the propensity-matched retrospective study com-
paring PCI and CABG as revascularization strategies
for isolated proximal LAD disease presented by
Hannan et al. (12) in this issue of the Journal provides
renewed insight into the era of contemporary DES.The investigators obtained data for 6,064 patients
with proximal LAD disease (5,340 DES and 724 CABG)
from reliable sources, such as New York State’s clin-
ical registries for PCI and for CABG. They minimized
selection bias by identifying 715 CABG and/or DES
pairs using propensity score matching. No differences
in all-cause mortality between the 2 revascularization
strategies were reported after a median 2.5-year
follow-up, which is consistent with ﬁndings from
previous trials (6–9), contemporary studies (13), and
meta-analyses involving the use of DES (14,15). This
may be because most enrolled patients were younger
and healthier, had better left ventricular function and
lesser comorbidities, and commonly underwent
elective or (at the most) urgent procedures. Because
such low-risk patients experience fewer early and
late procedure-related deaths, larger numbers would
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2728need to be treated to elicit a signiﬁcant difference in
mortality. Moreover, follow-up periods in all but 1
trial (6) and in most studies, including the current
study (12), were too short to reveal a survival advan-
tage favoring surgery.
There was a similar trend for the composite
endpoint of mortality, MI, and/or stroke, despite the
performance of almost one-half of the CABG pro-
cedures using a cardiopulmonary bypass (CPB) ma-
chine, which accounts for the majority of
complications (especially MI and stroke) after con-
ventional CABG. MIDCAB offers an off-pump LIMA to
LAD graft through a left anterior small thoracotomy
approach, thus avoiding CPB machine use, a median
sternotomy, and their potential complications. The
only drawback is the procedure’s steep learning
curve, during which complications that could require
conversion to sternotomy are more likely. Despite
its challenging operative technique, MIDCAB is
associated with low post-operative mortality and
morbidity, especially in high-volume centers that
regularly perform this operation, where MIDCAB is
the preferred surgical revascularization method for
isolated LAD disease (16).
The current series conﬁrms repeat TVR as the
Achilles heel of PCI, even in the era of DES. Although
most repeat TVRs occur within the ﬁrst post-PCI year
(6,15), the repeat revascularization rate remains
signiﬁcantly higher than for surgery, even at 10 years
(6,14). The reasons for this may be multifactorial.
First, most CABG patients receive a LIMA to LAD
graft, which has a patency rate as high as 95% to 98%
at 10- to 20-year follow-up (17). Secondly, bypass
grafts provide an alternative source of inﬂow and an
outﬂow point that is commonly located substantially
distal to the diseased LAD segment, which protects
against future disease development and progression.
In contrast, PCI is performed within the diseased
segment of the LAD, subjecting the distal vessel to
compromised ﬂows in the event of in-stent or in-
segment restenosis. At least in the near future, it isuncertain whether stent technology will supersede a
LIMA to LAD bypass graft as the treatment of choice
for isolated proximal LAD disease.
The current study failed to provide information on
the recurrence of angina and the consequences of
repeat TVR. Two meta-analyses revealed that the
relative risk of recurrent angina was 2.5 times higher
in the PCI cohort compared with the MIDCAB cohort
at 2 to 5 years of follow-up (11,15); this probably
occurred because of the higher restenosis rates after
PCI. This translates to more repeat TVR after PCI,
which negatively affects MACCE rates (13). Recurrent
angina and repeat TVR reduce quality of life and
result in repeated hospital admissions, thus esca-
lating the long-term costs of PCI that offset the
initially higher costs of surgery (18). Another draw-
back of the current study is the lack of description of
the lesions’ complexity, a primary prerequisite in
deciding on the optimal choice of therapy. PCI is
extremely challenging in patients with calciﬁed,
occluded, or bifurcation lesions and highly tortuous
vessels, and, in such cases, is associated with higher
rates of procedural failure and suboptimal results.
Conversely, CABG procedural success and prognosis
is determined by vessel quality at the anastomotic
site and the distal coronary tree. A heart team
approach would therefore be ideal in deciding the
best therapy to be used in patients with borderline
lesions and multiple comorbidities.
In summary, although the current study (12) re-
ported no differences in mortality or in the composite
endpoint of mortality, MI, and/or stroke between
CABG and DES, it did provide further evidence that
repeat TVR occurs signiﬁcantly more frequently after
PCI of the proximal LAD than after CABG, even in
real-world practice.
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